Navigation

Rheumatoid arthritis - certolizumab pegol

Certolizumab pegol for the treatment of rheumatoid arthritis

Status: History
Expected date of issue: February 2010
Referral date: December 2006
Process: STA
Topic area:
  • Musculoskeletal
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Helen Tucker
Communications manager: Tonya Gillis
Project manager: Bijal Joshi
Assessment Group / Evidence Review Group: West Midlands Health Technology Assessment Collaboration
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 22 June 2009
1st appraisal committee meeting: 23 September 2009
2nd appraisal committee meeting 17 November 2009
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers / Sponsors

  • UCB (certolizumab)

Patient / Carer Groups

  • Action on Pain
  • Afiya Trust
  • Age Concern England
  • Arthritic Association
  • Arthritis & Musculoskeletal Alliance (ARMA)
  • Arthritis Care
  • BackCare
  • Black Health Agency
  • Brain and Spine Foundation
  • British Ethnic Health Awareness  Foundation (BEHAF)
  • Chinese National Healthy Living Centre
  • Confederation of Indian Organisations
  • Counsel and Care
  • Equalities National Council
  • Help the Aged
  • Leonard CheshireDisability
  • Muslim Council of Great Britain
  • Muslim Health Network
  • National Rheumatoid Arthritis Society
  • Pain Concern
  • Pain Relief Foundation
  • Royal Association for Disability & Rehabilitation (RADAR)
  • South Asian Health Foundation
  • Specialised Healthcare Alliance

Professional Groups

  • British Association for Services to the Elderly
  • British Geriatrics Society
  • British Health Professionals in Rheumatology
  • British Institute of Musculoskeletal Medicine
  • British Orthopaedic Association
  • British Pain Society
  • British Society for Rheumatology
  • British Society of Rehabilitation Medicine
  • Physiotherapy Pain Association
  • Primary Care Rheumatology Society
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians
  • Royal Pharmaceutical Society
  • Royal Society of Medicine – Intellectual Disabilities Forum
  • United Kingdom Clinical Pharmacy Association

Others

  • Barnsley PCT
  • Brent PCT
  • Department of Health
  • Welsh Assembly Government

General

  • Age Concern Cymru
  • Board of Community Health Councils in Wales
  • British National Formulary
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Association of Primary Care
  • National Public Health Service for Wales
  • NHS Alliance
  • NHS Confederation
  • NHS Purchasing and Supply Agency
  • NHS Quality Improvement Scotland
  • Scottish Medicines Consortium

Possible comparator manufacturer(s)

  • A A H Pharmaceuticals (azathioprine, sulfasalazine)
  • Abbott Laboratories (adalimumab)
  • Actavis (azathioprine, sulfasalazine, penicillamine)
  • Alliance Pharmaceuticals (penicillamine)
  • Almus Pharmaceuticals (sulfasalazine)
  • Arrow Generics (azathioprine)
  • Astellas (auranofin)
  • AstraZeneca UK (chloroquine)
  • Dowelhurst (azathioprine, sulfasalazine, penicillamine)
  • Focus Pharmaceuticals (azathioprine)
  • Generics (UK) (azathioprine, sulfasalazine, penicillamine)
  • GlaxoSmith Kline (azathioprine)
  • IVAX Pharmaceuticals (azathioprine, sulfasalazine)
  • Kent Pharmaceuticals (azathioprine, sulfasalazine, penicillamine)
  • Novartis (ciclosporin)
  • Pfizer (sulfasalazine)
  • Roche Products (tocilizumab, rituximab)
  • Sandoz (azathioprine)
  • Sanofi Aventis (hydroxychloroquine, leflunomide, sodium aurothiomalate)
  • Schering-Plough (infliximab)
  • Teva UK (azathioprine, sulfasalazine, penicillamine)
  • UniChem (azathioprine, sulfasalazine, penicillamine)
  • Waymade Healthcare (sulfasalazine)
  • Wyeth Pharmaceuticals (etanercept)

Relevant research groups

  • Arthritis Research Campaign
  • Chronic Pain Policy Coalition
  • MRC Clinical Trials Unit
  • National Institute for Health Research
  • Policy Research Institute on Ageing and Ethnicity
  • Research Institute for the Care of Older People
  • Society for Back Pain Research
  • United Kingdom Clinical Research Network

Evidence Review Group

  • West Midlands Health Technology Assessment Collaboration
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • National Institute for Health Research (NIHR) Health Technology Assessment Programme (HTA Programme)

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 22 October 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.